Skip to main content
padlock icon - secure page this page is secure

Helicobacter pylori Treatment: An Overview in 2015

Buy Article:

$68.00 + tax (Refund Policy)

Introduction: H. pylori is a flagellate Gram-negative bacterium living on the mucosal surface of the gastric epithelium. It is accepted that the antibiotic resistance is a major problem for treatment of diseases caused by infectious bacteria. Infection is generally acquired during childhood and persists life-long in the absence of antibiotic treatment. Because of development of quinolone-resistant pathogens, quinolone-based triple therapy is not recommended as first-line therapy. In the case of H. pylori treatment we should also be well prepared to face with H. pylori treatment failures. Methods: To determine current status of the treatment failure, we have investigated recent papers in databases. Results: After the failure of first and second lines therapy of H. pylori infection, a culture-guided therapy has been recommended. Local surveillance of antibiotic resistance for all antibiotics used in H. pylori eradication regimens seems a practically possible suggestion to battle against this mysterious infection. More research is required to develop more effective therapeutic approaches. Conclusion: The main aims should be the maintenance of a high eradication rate of H. pylori and also successful prevention actions of increased antibiotic resistance. The purpose of this review is to provide an overview about the current knowledge of H. pylori treatment in 2015; also suggesting possible solutions for difficulties in close future.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Antibiotic resistance; Helicobacter pylori; treatment

Document Type: Research Article

Publication date: August 1, 2015

More about this publication?
  • Anti-Infective Agents publishes original research, expert reviews, drug clinical trial studies and guest edited issues on all the latest and outstanding developments on the medicinal chemistry, biology, pharmacology and use of anti-infective and anti-parasitic agents. The scope of the journal covers all pre-clinical and clinical research on antimicrobials, antibacterials, antiviral, antifungal, and antiparasitic agents. Anti-Infective Agents is an essential journal for all infectious disease researchers in industry, academia and the health services.
  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Subscribe to this Title
  • Information for Advertisers
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more